There have been many stocks which have managed to make strong moves over the course of the past week and one of those is the AREV Life Sciences Global Corp (OTCMKTS:AREVF). During the period, the stock has managed to emerge as a notable gainer and delivered gains of much as 8%.
Trading Data
On Thursday, AREVF stock ended flat at $0.2165 with more than 160 shares, compared to its average volume of 9.7k shares. The stock has moved within a range of $0.2165 – 0.2165 after opening trade at $0.2165.
AREV Life Sciences Settles Pending Litigation with Harvey
As it happens, the company was in focus on Thursday after it announced that it had been successful in agreeing a confidential settlement with the BC Bud Depot Assets vendor Matthew Harvey. The settlement was reached by the company during the course of a formal mediation that took place before the trial.
The settlement was an important development for the company considering the events from last year. Back on January 31, 2020, AREV Life Sciences had started litigation over agreement breaches by Matthew Harvey at the Supreme Court of British Columbia.
After the settlement was reached yesterday, the company noted that it was pleased with the outcome from the mediation process. That being said, the specific details of the settlement were not revealed since the mediation process is supposed to be confidential. That being said, the end of the whole skirmish now allows the company to move forward with its business.
Technical Data
AREVF stock is trading in the neutral zone as RSI stands at 62. The stock is trading above the 20-Day and 50-Day Moving averages of $0.1929 and $0.1490 respectively. The stock is down 54% in the past month.
